Ultragenyx Stock Price on January 10, 2025
| RARE Stock | USD 45.78 0.41 0.90% |
Below is the normalized historical share price chart for Ultragenyx extending back to January 31, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Ultragenyx stands at 45.78, as last reported on the 7th of February, with the highest price reaching 46.50 and the lowest price hitting 44.68 during the day.
If you're considering investing in Ultragenyx Stock, it is important to understand the factors that can impact its price. Ultragenyx owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0551, which indicates the firm had a -0.0551 % return per unit of risk over the last 3 months. Ultragenyx exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Ultragenyx's Risk Adjusted Performance of (0.04), coefficient of variation of (1,859), and Variance of 6.1 to confirm the risk estimate we provide.
At present, Ultragenyx's Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 4.4 B, whereas Common Stock Shares Outstanding is forecasted to decline to about 50.9 M. . At present, Ultragenyx's Price Earnings To Growth Ratio is projected to increase slightly based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 16.58, whereas Price Earnings Ratio is forecasted to decline to (5.48). Ultragenyx Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 31st of January 2014 | 200 Day MA 47.2288 | 50 Day MA 44.459 | Beta 0.581 |
Ultragenyx |
Sharpe Ratio = -0.0551
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | RARE |
Estimated Market Risk
| 2.56 actual daily | 22 78% of assets are more volatile |
Expected Return
| -0.14 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Ultragenyx is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ultragenyx by adding Ultragenyx to a well-diversified portfolio.
Price Book 12.08 | Enterprise Value Ebitda (6.46) | Price Sales 8.0872 | Shares Float 89 M | Wall Street Target Price 91.8 |
Related Headline
Inozyme Pharma Headline on 10th of January 2025
Inozyme Pharma Announces Positive Interim Data for INZ-701 i... by finance.yahoo.com
- Positive interim results in infants and young children with ENPP1 Deficiency showed improvements from baseline in multiple measures of disease, including survival, heart function, and stabilization or reduction in ectopic calcification and hypophosphatemia, with no radiographic evidence of rickets - Enrollment complete in ENERGY 3 pivotal trial in pediatric patients with ENPP1 Deficiency on track to complete dosing in January 2026, with topline data to follow in early 2026 - Regulatory gu
Ultragenyx Valuation on January 10, 2025
It is possible to determine the worth of Ultragenyx on a given historical date. On January 10, 2025 Ultragenyx was worth 43.29 at the beginning of the trading date compared to the closed value of 42.07. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Ultragenyx stock. Still, in general, we apply an absolute valuation method to find Ultragenyx's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Ultragenyx where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Ultragenyx's related companies.
| Open | High | Low | Close | Volume | |
| 44.40 | 44.78 | 43.28 | 43.65 | 612,851 | |
01/10/2025 | 43.29 | 43.72 | 41.58 | 42.07 | 833,991 |
| 41.00 | 43.23 | 40.50 | 43.16 | 2,179,772 |
| Backtest Ultragenyx | | | Ultragenyx History | | | Ultragenyx Valuation | Previous | Next |
Ultragenyx Trading Date Momentum on January 10, 2025
| On January 13 2025 Ultragenyx was traded for 43.16 at the closing time. The top price for the day was 43.23 and the lowest listed price was 40.50 . The trading volume for the day was 2.2 M. The trading history from January 13, 2025 was a factor to the next trading day price growth. The trading delta at closing time against the next closing price was 2.59% . The trading price change against the current closing price is 3.80% . |
Ultragenyx Fundamentals Correlations and Trends
By evaluating Ultragenyx's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Ultragenyx's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Ultragenyx financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Ultragenyx Stock history
Ultragenyx investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Ultragenyx is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Ultragenyx will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Ultragenyx stock prices may prove useful in developing a viable investing in Ultragenyx
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 84.6 M | 50.9 M | |
| Net Loss | -636.7 M | -604.8 M |
Ultragenyx Quarterly Net Working Capital |
|
Ultragenyx Stock Technical Analysis
Ultragenyx technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Ultragenyx Period Price Range
Low | February 7, 2025
| High |
0.00 | 0.00 |
Ultragenyx cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Ultragenyx February 7, 2025 Market Strength
Market strength indicators help investors to evaluate how Ultragenyx stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Ultragenyx shares will generate the highest return on investment. By undertsting and applying Ultragenyx stock market strength indicators, traders can identify Ultragenyx entry and exit signals to maximize returns
Ultragenyx Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Ultragenyx's price direction in advance. Along with the technical and fundamental analysis of Ultragenyx Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Ultragenyx to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.22) | |||
| Total Risk Alpha | (0.40) | |||
| Treynor Ratio | (0.17) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Ultragenyx Stock analysis
When running Ultragenyx's price analysis, check to measure Ultragenyx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ultragenyx is operating at the current time. Most of Ultragenyx's value examination focuses on studying past and present price action to predict the probability of Ultragenyx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ultragenyx's price. Additionally, you may evaluate how the addition of Ultragenyx to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Stocks Directory Find actively traded stocks across global markets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |